This amendment removes copayments for HIV PrEP (pre-exposure prophylaxis) and HIV PEP (post-exposure prophylaxis) drug products to align with both the US Preventive Services Task Force Guidelines for prevention of acquisition of HIV and the CDC's Clinical Guidance for HIV PEP.
State
Approval Date
Effective Date
File 1 - Approval Document Media